News related to Cyanocobalamin Injection and/or conditions it is approved for
Nerve Protecting Agents May Help Prevent Chemotherapy-Induced Anemia
Source: Blood / Hematology News From Medical News Today [2013.05.08]
Cancer chemotherapy can cause peripheral neuropathy - nerve damage often resulting in pain and muscle weakness in the arms and legs. Now, researchers at Albert Einstein College of Medicine of Yeshiva University have discovered that chemo also induces an insidious type of nerve damage inside bone marrow that can cause delays in recovery after bone marrow transplantation...
Loss of Key Blood Cell Gene Tied to Anemia, Animal Research Suggests
Source: MedicineNet Anemia Specialty [2012.11.08]
Title: Loss of Key Blood Cell Gene Tied to Anemia, Animal Research Suggests
Category: Health News
Created: 11/7/2012 2:36:00 PM
Last Editorial Review: 11/8/2012 12:00:00 AM
Anemia During Pregnancy
Source: MedicineNet Spina Bifida and Anencephaly Specialty [2012.04.18]
Title: Anemia During Pregnancy
Category: Doctor's & Expert's views on Symptoms
Created: 4/10/2012 1:55:00 PM
Last Editorial Review: 4/18/2012 12:00:00 AM
Anemia
Source: MedicineNet Alpha Thalassemia Specialty [2012.03.26]
Title: Anemia
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 3/26/2012 12:00:00 AM
Pernicious Anemia
Source: MedicineNet Thyroid Peroxidase Test Specialty [2009.11.20]
Title: Pernicious Anemia
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 11/20/2009 12:00:00 AM
Sickle Cell Disease (Sickle Cell Anemia)
Source: MedicineNet Aseptic Necrosis Specialty [2006.12.04]
Title: Sickle Cell Disease (Sickle Cell Anemia)
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 12/4/2006 12:00:00 AM
Warning didn't change for-profit dialysis drug use
Source: Yahoo! Health News [2013.05.16]
By Andrew M. Seaman NEW YORK (Reuters Health) - Despite a strong warning from U.S. regulators in 2007, for-profit dialysis centers still gave their kidney failure patients more of a certain anemia drug than non-profit centers in 2008, says a new s...
Better Outcomes In Anemic Surgical Patients With Fewer Transfusion-Related Complications With Single, High-Dose Erythropoietin
Source: Blood / Hematology News From Medical News Today [2013.05.08]
Anemia increases operative mortality and morbidity in non-cardiac and cardiac surgical procedures. Anemic surgical patients may require more blood transfusions, raising the risk of transfusion-related complications and increasing costs. For those reasons, optimizing patient readiness by correcting anemia prior to surgery is an important clinical goal...
Aranesp Misbranding - Amgen Agrees $762 Million Payment
Source: Litigation / Medical Malpractice News From Medical News Today [2012.12.19]
After being found guilty of promoting off-label use of Aranesp (darbepoetin alfa), an anemia drug, Amgen Inc. agreed to pay $150 million in criminal fines and penalties. Prosecutors added that the company will also pay $612 in civil settlements. The settlement would include a payment to a former Aranesp product manager, Kassie Westmoreland, to resolve a whistleblower lawsuit...
FDA approves extended dosing of Aranesp
Source: The Doctors Lounge - Hematology
FDA has approved every-3-week dosing of Aranesp (darbepoetin alfa) for treatment of chemotherapy - induced anemia.
|
